Tag Archives: Heparin Market

Heparin Market Research Report Forecast to 2024

The heparin market in Europe is rather consolidated, with the Sanofi, Aspen, Pfizer, and Leo Pharma accounting for over 65% of the market in 2015. In a new study, Transparency Market Research (TMR) has found that Sanofi is the clear leader in the Europe heparin market, enjoying a 47.5% share in 2015. Increased global sales of Lovenox can be attributed to the company’s success.

“A focus on the expansion of R&D activities, in-licensing and acquisitions, and portfolio management are the key strategies adopted by the market leader,” the author of the study finds. In 2015, the company spent over US$5 bn on the research and development of 18 new medicines and vaccines. Companies in the heparin market in Europe are also emphasizing on key BRIC-M countries, developing market-specific innovations, and prioritizing resource allocation.

Heparin Market is expanding at a CAGR of 5.2% from 2016 to 2024

The heparin market in Europe is rather consolidated, with the Sanofi, Aspen, Pfizer, and Leo Pharma accounting for over 65% of the market in 2015. In a new study, Transparency Market Research (TMR) has found that Sanofi is the clear leader in the Europe heparin market, enjoying a 47.5% share in 2015. Increased global sales of Lovenox can be attributed to the company’s success.

“A focus on the expansion of R&D activities, in-licensing and acquisitions, and portfolio management are the key strategies adopted by the market leader,” the author of the study finds. In 2015, the company spent over US$5 bn on the research and development of 18 new medicines and vaccines. Companies in the heparin market in Europe are also emphasizing on key BRIC-M countries, developing market-specific innovations, and prioritizing resource allocation.

Global Heparin Market by Type & Application 2015 – 2023

Global Heparin Market: Key Trends 

The prevalence of coagulation disorders such as venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE) has remarkably increased in both Europe and North America. Since heparin is one of the foremost clinical anticoagulants, the rising incidence of coagulation disorders will in turn fuel demand for heparin products, finds Transparency Market Research (TMR). Currently, heparin manufacturers are focusing on the development of generic versions of heparin to gain a competitive advantage in the market.

Heparin Market – Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Hence, the demand for heparin in Europe is expected to increase in the next few years. The heparin market in Europe was valued at US$2.2 bn in 2015 and is projected to expand at a CAGR of 5.2% from 2016 to 2024 to reach US$3.5 bn in 2024.

Heparin Market Analysis and In-Depth Analysis on Market Dynamics, Emerging Trends, Growth Factors and Sales Forecast to 2021

Heparin Market Report Forecast 2017-2021 is a respected source of insightful data for business planners. Global Heparin Market provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data.

The research analysts provide an elaborate description of the value chain and its distributor analysis. This Heparin Market industry report study provides analysis based on Geographical Regions, Manufacturers, Applications, Types, Drivers, Opportunities, and Challenges which enhances the understanding, scope and application of this report.

Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Global Heparin Market @ http://www.360marketupdates.com/10487346

Global Heparin Market Key Trends & Industry Forecast 2015 – 2023

Global Heparin Market: Key Trends 

The prevalence of coagulation disorders such as venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE) has remarkably increased in both Europe and North America. Since heparin is one of the foremost clinical anticoagulants, the rising incidence of coagulation disorders will in turn fuel demand for heparin products, finds Transparency Market Research (TMR). Currently, heparin manufacturers are focusing on the development of generic versions of heparin to gain a competitive advantage in the market.

Heparin Report on Worldwide Market Growth, Development to 2017-2021

HTF Market Intelligence released a new research report of 115 pages on title ‘World Heparin Market by Product Type, Market, Players and Regions-Forecast to 2021’ with detailed analysis, forecast and strategies. The study covers key region that includes USA, Europe, Japan, China and India and important players such as Hepalink , Helm AG, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. and other players.

Request a sample report @ https://www.htfmarketreport.com/sample-report/219740-world-heparin-market

Summary

Heparin market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.

Europe Heparin Market to register a steady CAGR of 5.2% from 2016 to 2024

Europe Heparin Market: Snapshot

Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Hence, the demand for heparin in Europe is expected to increase in the next few years. The heparin market in Europe was valued at US$2.2 bn in 2015 and is projected to expand at a CAGR of 5.2% from 2016 to 2024 to reach US$3.5 bn in 2024.

Designed by CyFocus.com
Powered by CyFocus.net